BDSX

Companies
NASDAQ
Biodesix Inc.
Health Care
Price Chart
Overview

About BDSX

biodesix develops and commercializes blood-based molecular diagnostic tests that advance the standard of care in oncology. our diagnostics help patients and their doctors make more informed decisions about treatment based on a patient's unique molecular profile. we're advancing precision medicine by helping physicians provide the right patient with the right treatment at the right time, and move patients to optimal treatment faster. we partner with pharmaceutical companies to develop tests that accelerate pipelines and bring effective therapies to market. our two commercialized tests, veristrat® & genestrat™, offer results in 72 hours. no tissue is required.

Market Cap
$152.5M
Volume
2.3M
Avg. Volume
848.7K
P/E Ratio
-1.2309091
Dividend Yield
0.00%
Employees
234.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Diagnostics & Research
Risk & Correlation Analysis
Market Correlation
0.60
Low Correlation
Volatility
High (0.75)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for BDSX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, BDSX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$152.5M
Volume2.3M
P/E Ratio-1.23
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025

PortfolioPilot Analysis

Get AI-powered insights on how BDSX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025